Abstract
Neurodegenerative diseases are rare in childhood. Most of them result from disturbances in the metabolism of energy, lipids, amino acids or metals. Symptoms may not appear before childhood or adolescence, but some are fatal in utero or in the neonatal period; they form the core of this overview. Before starting a postmortem examination, clinical and radiological findings should be obtained, because they may yield important diagnostic clues. Neuropathologically, a useful starting point is to establish whether the gray or the white matter is primarily affected. Microscopically, the neuropathological features can be diagnostic for a certain disease, but in most cases additional biochemical, genetic and molecular studies are required to come to a final diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Wong V. Neurodegenerative diseases in children. Hong Kong Med J. 1997;3:89–95.
Pierre G. Neurodegenerative disorders and metabolic disease. Arch Dis Child. 2013;98:618–24.
Volpe JJ. Neurology of the newborn. 5th ed. Philadelphia, PA: Saunders/Elsevier; 2008.
Verity C, Winstone AM, Stellitano L, Will R, Nicoll A. The epidemiology of progressive intellectual and neurological deterioration in childhood. Arch Dis Child. 2010;95:361–4.
Maroun LL, Graem N. Autopsy standards of body parameters and fresh organ weights in nonmacerated and macerated human fetuses. Pediatr Dev Pathol. 2005;8:204–17.
Friede RL. Developmental neuropathology. Berlin: Springer; 1989.
Folkerth RD, Lidov HGW. Congenital malformations, perinatal diseases, and phacomatoses. In: Prayson RA, editor. Neuropathology. 2nd ed. Philadelphia: Elsevier Saunders; 2012. p. 96–182.
Dawson TP, Neal JW, Llewellyn L, Thomas C. Neuropathology techniques. London: Hodder Arnold; 2003.
Ellison D, Love S, Chimelli L, Harding BN. Neuropathology: a reference text of CNS pathology. 3rd ed. London: Elsevier/Mosby; 2013.
Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249–54.
Okada S, O’Brien JS. Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component. Science. 1969;165:698–700.
Suzuki K, Suzuki K. Lysosomal diseases. In: Love S, Louis DN, Ellison DW, editors. Greenfield’s neuropathology. 8th ed. London: Hodder Arnold; 2008. p. 515–99.
Charrow J. Ashkenazi Jewish genetic disorders. Familial Cancer. 2004;3:201–6.
Smith NJ, Winstone AM, Stellitano L, Cox TM, Verity CM. GM2 gangliosidosis in a UK study of children with progressive neurodegeneration: 73 cases reviewed. Dev Med Child Neurol. 2012;54:176–82.
Purpura DP, Suzuki K. Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res. 1976;116:1–21.
Purpura DP. Ectopic dendritic growth in mature pyramidal neurones in human ganglioside storage disease. Nature. 1978;276:520–1.
Walkley SU, Pierok AL. Ferric ion-ferrocyanide staining in ganglioside storage disease establishes that meganeurites are of axon hillock origin and distinct from axonal spheroids. Brain Res. 1986;382:379–86.
Haltia M. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol. 2003;62:1–13.
Haltia M. The neuronal ceroid-lipofuscinoses: from past to present. Biochim Biophys Acta. 1762;2006:850–6.
Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J, et al. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain. 2006;129:1438–45.
Anderson GW, Goebel HH, Simonati A. Human pathology in NCL. Biochim Biophys Acta. 1832;2013:1807–26.
Schuchman EH. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. J Inherit Metab Dis. 2007;30:654–63.
Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 1997;277:228–31.
Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, et al. Identification of HE1 as the second gene of Niemann-Pick C disease. Science. 2000;290:2298–301.
Chen M, Wang J. Gaucher disease: review of the literature. Arch Pathol Lab Med. 2008;132:851–3.
Stone DL, van Diggelen OP, de Klerk JB, Gaillard JL, Niermeijer MF, Willemsen R, et al. Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease? Eur J Hum Genet. 1999;7:505–9.
Stone DL, Carey WF, Christodoulou J, Sillence D, Nelson P, Callahan M, et al. Type 2 Gaucher disease: the collodion baby phenotype revisited. Arch Dis Child Fetal Neonatal Ed. 2000;82:F163–6.
Sidransky E, Tayebi N, Stubblefield BK, Eliason W, Klineburgess A, Pizzolato GP, et al. The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease. J Med Genet. 1996;33:132–6.
Harding BN, Egger J, Portmann B, Erdohazi M. Progressive neuronal degeneration of childhood with liver disease. A pathological study. Brain. 1986;109:181–206.
Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol. 1990;5:273–87.
Naviaux RK, Nguyen KV. POLG mutations associated with Alpers’ syndrome and mitochondrial DNA depletion. Ann Neurol. 2004;55:706–12.
Harding BN, Surtees RAH. Metabolic and neurodegenerative diseases of childhood. In: Love S, Louis DN, Ellison DW, editors. Greenfield’s neuropathology. 8th ed. London: Hodder Arnold; 2008. p. 481–514.
Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet. 1993;3:7–13.
Menkes JH. Kinky hair disease: twenty five years later. Brain Dev. 1988;10:77–9.
Costello DJ, Eichler AF, Eichler FS. Leukodystrophies: classification, diagnosis, and treatment. Neurologist. 2009;15:319–28.
Cheon JE, Kim IO, Hwang YS, Kim KJ, Wang KC, Cho BK, et al. Leukodystrophy in children: a pictorial review of MR imaging features. Radiographics. 2002;22:461–76.
Kinney HC, Brody BA, Kloman AS, Gilles FH. Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J Neuropathol Exp Neurol. 1988;47:217–34.
Matalon R, Michals K, Kaul R. Canavan disease: from spongy degeneration to molecular analysis. J Pediatr. 1995;127:511–7.
Rodriguez D, Gauthier F, Bertini E, Bugiani M, Brenner M, N'Guyen S, et al. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet. 2001;69:1134–40.
Kobayashi T, Goto I, Yamanaka T, Suzuki Y, Nakano T, Suzuki K. Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine. Ann Neurol. 1988;24:517–22.
Sahai I, Baris H, Kimonis V, Levy HL. Krabbe disease: severe neonatal presentation with a family history of multiple sclerosis. J Child Neurol. 2005;20:826–8.
Wolf NI, Sistermans EA, Cundall M, Hobson GM, Davis-Williams AP, Palmer R, et al. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease. Brain. 2005;128:743–51.
Koeppen AH, Robitaille Y. Pelizaeus-Merzbacher disease. J Neuropathol Exp Neurol. 2002;61:747–59.
Scheffer IE, Baraitser M, Wilson J, Harding B, Kendall B, Brett EM. Pelizaeus-Merzbacher disease: classical or connatal? Neuropediatrics. 1991;22:71–8.
DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348:2656–68.
Zeviani M, Di Donato S. Mitochondrial disorders. Brain. 2004;127:2153–72.
Brown GK, Squier MV. Neuropathology and pathogenesis of mitochondrial diseases. J Inherit Metab Dis. 1996;19:553–72.
Volpe JJ, Adams RD. Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration. Acta Neuropathol. 1972;20:175–98.
Evrard P, Caviness VS Jr, Prats-Vinas J, Lyon G. The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis bases upon cytoarchitectonic analysis. Acta Neuropathol. 1978;41:109–17.
Feigin I, Kim HS. Subacute necrotizing encephalomyelopathy in a neonatal infant. J Neuropathol Exp Neurol. 1977;36:364–72.
Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol. 2008;39:223–35.
Lake NJ, Compton AG, Rahman S, Thorburn DR. Leigh syndrome: one disorder, more than 75 monogenic causes. Ann Neurol. 2016;79:190–203.
Lake NJ, Bird MJ, Isohanni P, Paetau A. Leigh syndrome: neuropathology and pathogenesis. J Neuropathol Exp Neurol. 2015;74:482–92.
Pirot N, Crahes M, Adle-Biassette H, Soares A, Bucourt M, Boutron A, et al. Phenotypic and neuropathological characterization of fetal pyruvate dehydrogenase deficiency. J Neuropathol Exp Neurol. 2016;75:227–38.
Grunewald S, Matthijs G, Jaeken J. Congenital disorders of glycosylation: a review. Pediatr Res. 2002;52:618–24.
Freeze HH. Congenital disorders of glycosylation: CDG-I, CDG-II, and beyond. Curr Mol Med. 2007;7:389–96.
Marquardt T, Denecke J. Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr. 2003;162:359–79.
Martin JJ, Schlote W. Central nervous system lesions in disorders of amino-acid metabolism. A neuropathological study. J Neurol Sci. 1972;15:49–76.
Kolodny EH. Agenesis of the corpus callosum: a marker for inherited metabolic disease? Neurology. 1989;39:847–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jansen, C. (2022). Degenerative and Metabolic Brain Diseases. In: Khong, T.Y., Malcomson, R.D.G. (eds) Keeling's Fetal and Neonatal Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-84168-3_29
Download citation
DOI: https://doi.org/10.1007/978-3-030-84168-3_29
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84167-6
Online ISBN: 978-3-030-84168-3
eBook Packages: MedicineMedicine (R0)